重症流感危重患者中的侵袭性气管支气管曲霉病:一项临床试验
这项回顾性观察研究纳入2010至2019年间三家医院ICU中35例重症流感合并肺曲霉病的危重患者,其中10例(28.6%)为侵袭性气管支气管曲霉病(ITBA)。ITBA组90天死亡率为90%,显著高于非ITBA组的44%(P=0.02),且血清和BAL液半乳甘露聚糖及1,3-β-D-葡聚糖浓度更高。建议对ICU中流感合并肺曲霉病患者系统行支气管镜检查。
要点
- 重症流感合并肺曲霉病的ICU患者中,ITBA占28.6%(10/35)。
- ITBA组90天死亡率为90%,显著高于非ITBA组的44%(P=0.02)。
- ITBA组血清和BAL液GM及1,3-β-D-葡聚糖浓度显著更高。
核心结论
- ITBA与更高的病情严重评分、死亡率及血清和BAL液半乳甘露聚糖和1,3-β-D-葡聚糖浓度相关。
- 对ICU中流感合并肺曲霉病患者应系统行支气管镜检查以排查ITBA。
研究设计与样本
- 回顾性观察性研究,纳入2010至2019年三家医院ICU中重症流感合并肺曲霉病的危重患者35例。
- ITBA组10例(28.6%),非ITBA组25例。
主要发现
- ITBA组90天死亡率为90%,非ITBA组为44%(P=0.02)。
- ITBA组血清1,3-β-D-葡聚糖浓度显著高于非ITBA组(P<0.0001)。
- ITBA组血清半乳甘露聚糖浓度显著高于非ITBA组(P=0.003)。
- ITBA组BAL液半乳甘露聚糖浓度显著高于非ITBA组(P=0.008)。
- ITBA组中活动性吸烟、糖尿病及更高Simplified Acute Physiology Score II评分的患者更多。
临床怎么用
- 对ICU中重症流感合并肺曲霉病患者,应系统行支气管镜检查以评估ITBA。
- ITBA患者病情更重、死亡率更高,需加强监测与干预。
局限性
- 回顾性观察性研究,样本量较小(共35例)。
- 仅纳入三家医院ICU的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Invasive tracheobronchial aspergillosis (ITBA) is an uncommon but severe clinical form of invasive pulmonary aspergillosis in which the fungal infection is entirely or predominantly confined to the tracheobronchial tree.Objectives: To analyze the diagnostic and prognostic differences between tracheobronchial aspergillosis and pulmonary aspergillosis without tracheobronchial lesions among patients admitted to the ICU with severe influenza.Methods: This retrospective, observational study included critically ill patients with influenza associated with pulmonary aspergillosis from three hospital ICUs between 2010 and 2019. Patient characteristics and clinical and mycologic data at admission and during ICU stay were collected in a database to evaluate variables in the two groups.Measurements and Main Results: Thirty-five patients admitted to the ICU with severe influenza and pulmonary aspergillosis were included. Ten patients were included in the group with ITBA (n = 10 of 35; 28.6%), and 25 patients were included in the group without ITBA. The group with ITBA comprised more patients with active smoking, diabetes mellitus, and higher severity scores (Simplified Acute Physiology Score II). Ninety-day mortality rates in the groups with and without ITBA were 90% and 44%, respectively (P = 0.02). Moreover, significantly higher serum 1,3-β-d-glucan and galactomannan and BAL fluid galactomannan concentrations were observed in the group with ITBA compared with the group without ITBA (P < 0.0001, P = 0.003, and P = 0.008, respectively).Conclusions: ITBA was associated with higher severity scores, mortality, and serum and BAL fluid galactomannan and 1,3-β-d-glucan concentrations than invasive pulmonary aspergillosis without tracheobronchial lesions. ITBA should be systematically researched by bronchoscopic examination in ICU patients with concomitant pulmonary aspergillosis and influenza.Clinical trial registered with www.clinicaltrials.gov (NCT04077697).
引用
- Nyga R, Maizel J, Nseir S, et al. Invasive Tracheobronchial Aspergillosis in Critically Ill Patients with Severe Influenza. A Clinical Trial. Am J Respir Crit Care Med. 2020. PMID: 32407157. doi:10.1164/rccm.201910-1931OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。